Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-031106
Filing Date
2024-08-12
Accepted
2024-08-12 06:03:45
Documents
52
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 651340
2 ex31-1.htm EX-31.1 20670
3 ex32-1.htm EX-32.1 8311
4 GRAPHIC logo_001.jpg GRAPHIC 13546
  Complete submission text file 0001493152-24-031106.txt   3917028

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE gcan-20240630.xsd EX-101.SCH 30829
6 XBRL CALCULATION FILE gcan-20240630_cal.xml EX-101.CAL 30410
7 XBRL DEFINITION FILE gcan-20240630_def.xml EX-101.DEF 164823
8 XBRL LABEL FILE gcan-20240630_lab.xml EX-101.LAB 234306
9 XBRL PRESENTATION FILE gcan-20240630_pre.xml EX-101.PRE 206316
54 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 507618
Mailing Address 15 WALKER AVE, SUITE 101 BALTIMORE MD 21208
Business Address 15 WALKER AVE, SUITE 101 BALTIMORE MD 21208 (443) 738-4051
Greater Cannabis Company, Inc. (Filer) CIK: 0001695473 (see all company filings)

EIN.: 300842570 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56027 | Film No.: 241194613
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)